Yeast telomeres comprise irregular TG 1-3 DNA repeats bound by the general transcription factor Rap1. Rif1 and Rif2, along with Rap1, form the telosome, a protective cap that inhibits telomerase, counteracts SIR-mediated transcriptional silencing, and prevents inadvertent recognition of telomeres as DNA double-strand breaks. We provide a molecular, biochemical, and functional dissection of the protein backbone at the core of the yeast telosome. The X-ray structures of Rif1 and Rif2 bound to the Rap1 C-terminal domain and that of the Rif1 C terminus are presented. Both Rif1 and Rif2 have separable and independent Rap1-binding epitopes, allowing Rap1 binding over large distances (42-110 Å ). We identify tetramerization (Rif1) and polymerization (Rif2) modules that, in conjunction with the longrange binding, give rise to a higher-order architecture that interlinks Rap1 units. This molecular Velcro relies on Rif1 and Rif2 to recruit and stabilize Rap1 on telomeric arrays and is required for telomere homeostasis in vivo.
INTRODUCTION
The Saccharomyces cerevisiae repressor-activator protein 1 (Rap1) serves as a general transcriptional activator at about 300 genomic loci (Lieb et al., 2001; Shore and Nasmyth, 1987) . At the two HM silent mating type loci, Rap1 acts as a repressor of gene expression (gene silencing). Telomere-bound Rap1 is required for different aspects of telomere homeostasis, including telomere length regulation, inhibition of telomere end resection, protection from telomere fusion, and inhibition of undesired activation of the DNA damage checkpoint (reviewed in Wellinger and Zakian, 2012) .
Budding yeast telomere repeats are, on average, 300 bp in length, largely double-stranded, and capable of binding 15-20 Rap1 molecules per telomere (Gilson et al., 1993) . The sequence-specific DNA-binding protein Rap1 recognizes the double-stranded TG 1-3 DNA moiety directly (Longtine et al., 1989) and recruits the Rap1-interacting factors 1 and 2 (Rif1 and Rif2, respectively). Rif1 and Rif2 associate directly with the Rap1 C-terminal domain (Rap1 RCT ) in yeast two-hybrid (Y2H) experiments (Hardy et al., 1992; Wotton and Shore 1997) .
The different protective and regulatory roles of telomeres are not provided by Rap1 alone but in conjunction with other proteins that assemble a ''capping'' structure, also referred to as the telosome (Wright et al., 1992) . The mammalian capping complex is known as shelterin (reviewed in de Lange, 2005) . In budding yeast, the protective telomere cap is composed of Rap1-Rif1-Rif2, Ku70-Ku80, and the Cdc13-Stn1-Ten1 (CST) complex. The CST complex associates at the telomeric singlestranded 3 0 overhang, preventing its degradation during S phase (Vodenicharov and Wellinger, 2006) . The Ku70-Ku80 complex is a ubiquitous DNA end-binding factor that protects telomeres from resection in nondividing cells (Vodenicharov et al., 2010) . Complexes of Rap1-Rif1-Rif2, being the major protein components that bind double-stranded TG 1-3 repeats, serve in central aspects of telomere homeostasis.
The capping structure that forms through Rap1, Rif1, and Rif2 assembly at telomeres is the focus of this study. Wild-type (WT) telomere length is thought to be maintained by a feedback mechanism that controls telomerase action through an inhibitory signal whose strength is proportional to the amount of bound Rap1, Rif1, and Rif2 molecules (Marcand et al., 1997) . Consequently, loss of Rif1 or Rif2 results in elongated telomeres. Rif1 and Rif2 prevent telomeres from inadvertent recognition as a DNA double-strand break (DSB), thus contributing to telomere capping. Rif2 and Rap1 inhibit both nuclease access and nonhomologous end-joining (NHEJ) at telomeres (Marcand et al., 2008) , whereas the loss of Rif1 does not affect NHEJ and only slightly increases single-stranded DNA generation at telomeres (Marcand et al., 2008; Bonetti et al., 2010) . Instead, Rif1 reinforces the CST complex, given that Rif1 is required for cell viability specifically when CST activity is reduced (Anbalagan et al., 2011) . However, both Rif1 and Rif2 carry out nonoverlapping roles in preventing G2/M checkpoint activation at telomeric DNA ends that are flanked by only short arrays of TG 1-3 repeats (Ribeyre and Shore, 2012) .
In vitro, Rap1 molecules bind TG 1-3 repeats in an independent fashion, and there is no obvious crosstalk between individual Rap1 units (Williams et al., 2010) . No novel property emerges once multiple Rap1 sites are juxtaposed, as judged by the absence of cooperative binding (Gilson et al., 1993 ). Yet, in vivo, arrays of TG 1-3 Rap1-binding sites confer telomere capping properties once approximately 4-5 (or perhaps even fewer) Rap1-binding sites are present (Ribeyre and Shore, 2012) . It has been unclear what allows double-stranded arrays of Rap1-binding sites to act as a protective telomeric cap once a certain number of Rap1-binding sites are present. Why the proteinaceous cap is recruited to telomeres, but not to individual Rap1 sites, is a crucial question.
The focus of our study was to characterize the protein-protein interaction scaffold underlying the S. cerevisiae telomerecapping complex comprised of Rap1, Rif1, and Rif2. We set out to examine how these interactions form a capping structure on telomeric DNA and how they contribute to telomere homeostasis in vivo.
RESULTS

Rif2
Interacts through Distinct Epitopes with Two Adjacent Rap1 RCT Domains First, we examined Rif2 and its complex with Rap1. The structures of Rif2 (residues 66-380) alone ( Figure 1A ) and full-length Rif2 (1-395) in complex with the Rap1 C-terminal domain (Rap1 RCT : 672-827) were solved by X-ray crystallography (Figure 1B) and refined at a 2.9 and 3.3 Å resolution, respectively. In comparing Rif2 in complex with Rap1 and alone, no significant conformational changes are observed in Rif2. The structure of Rif2 identifies it as a member of the ATPase family associated with diverse cellular activities (AAA+) that exist in oligomeric or monomeric form (Figures S1A and S1B available online). We find that Rif2 is monomeric in solution ( Figure S1F ).
The Rif2 AAA+ structure consists of two lobes ( Figure 1A) , an a-helical domain composed of six helices (a0 and a6-a10) and an additional strand-conserved E family (ASCE) domain found as an insertion between a0 and a6. The defining feature of AAA+ proteins is the structurally conserved NTPase domain (ASCE domain), which contains Walker A (or P loop) and B motifs (reviewed in Erzberger and Berger, 2006) . Most AAA+ proteins function by linking ATP-mediated conformational changes within an oligomeric assembly to specific chemomechanical motions that direct the translocation or remodeling of target substrates. However, an increasing number of AAA+ proteins that are monomeric and not active as ATPases or do not even bind ATP have been identified. In the case of Rif2, the ATP-binding site within its AAA+ domain is degenerate ( Figures S1B and S1C ), and isolated Rif2 shows no measurable ATP hydrolysis (data not shown). We cannot rule out the importance of this site for ligand binding or posttranslational modification, given that mutations in the nucleotide-binding groove exhibited mild phenotypes in telomere length regulation and G2/M checkpoint response in vivo ( Figures S1D and S1E) . The Rif2 C terminus (371-395, referred to as Rif2 CTD ) ( Figure 1A ) does not contain discernible secondary structure elements and is found to be stabilized by packing interactions within the Rif2 crystal lattice.
In the Rif2-Rap1 complex structure ( Figure 1B ), we found that each Rif2 molecule binds to two different Rap1 RCT molecules through two independent interfaces: the Rif2 AAA+ domain (Rif2 AAA+ ) and an N-terminal extension peptide comprising residues 36-48 (subsequently referred to as the Rap1 RCT -binding module [Rif2 RBM ]). Conversely, one Rap1 RCT binds two Rif2 molecules ( Figure 1F ). The Rif2 AAA+ -Rap1 interaction is directed towards the N-terminal face of Rap1 RCT . Rap1 residues F708 and P705 interact with Rif2 residues L79, F342, and V350, participating in extended hydrophobic interactions ( Figure 1C) . A pronounced salt bridge is formed between Rif2 E347 and Rap1 R747 ( Figure 1C ). The interfaces between Rap1 H709 with Rif2 T346, as well as those between Rap1 R747 with Rif2 E347 ( Figure 1C ), are consistent with previous mapping attempts (Feeser and Wolberger, 2008 ). An additional minor interface is provided by Rif2 CTD , which we found sandwiched between the Rif2 a-helical bundle and the ASCE domain ( Figures 1B, 1D , and S2A). Hydrogen bonding interactions were observed between Rif2 L386, Q382, and A375 and Rap1 Q715, D742, and R747, respectively ( Figure 1D ). The second Rap1-binding interface is formed by Rif2 RBM , which attaches as a helix in a Rap1 RCT surface cleft formed by helices a3 through a6 ( Figures  1B and 1E ). The RBM peptide sequence could be assigned despite medium resolution and was validated by selenomethionine labeling in combination with mutagenesis ( Figures  S2B-S2D ). Rif2 RBM residues L42 and L44 bind to the Rap1 hydrophobic cleft provided by Rap1 residues L736, L755, L762, and A733 ( Figure 1E ). Interestingly, the Rif2 RBM epitope and the Rif2 AAA+ domain from one Rif2 molecule are unable to simultaneously engage with the same Rap1 molecule ( Figure 1F) ; the observed distance between the last visible residue in Rif2 RBM (K48) and the first visible residue of the Rif2 AAA+ domain (P61) comprises more than 60 Å in the crystal, whereas the maximally calculated root mean square (rms) end-to-end distance of the interjacent 14-residue linker (48-61) is only 42 Å (Miller and Goebel, 1968) . Therefore, the Rif2 RBM epitope originates from a second Rif2 molecule in the crystal lattice located 28 Å from the nearest Rap1 RCT .
A Single Rif2 Molecule Is Able to Bind Two Separate Rap1 Molecules In trans in Solution
The crystal structure indicated that the RBM and AAA+ interfaces of the same Rif2 molecule do not bind to a common Rap1 molecule, but, rather, they bind to two different Rap1 molecules. Furthermore, it predicts that Rif2 RBM /Rif2 AAA+ are able to autonomously bind Rap1. We used isothermal titration calorimetry (ITC) to independently validate the Rap1-and Rif2-binding mode observed in the crystal (Figures 1G-1I ). In solution, a Rif2 RBM epitope containing residues 30-49 bound Rap1 RCT with an affinity of 30 mM, as measured by ITC (stoichiometry N = 1.1 ± 0.2) ( Figure 1G ). A Rif2 construct without the RBMepitope, but retaining the AAA+ interface (Rif2 66-395), bound Rap1 RCT with an affinity of 50 mM (N = 1.05 ± 0.02) ( Figure 1H ). Thus, the two isolated RBM and AAA+ interfaces have comparable affinities (Rif2 RBM -Rap1 RCT , 30 ± 20 mM, versus Figure 1E versus Figure 1C-1D ). If both interfaces were to bind the same Rap1 molecule, the two dissociation constant (K d ) values would be expected to potentiate each other, resulting in a significantly higher overall affinity (by orders of magnitude) (Borsi et al., 2010) . On the other hand, if the two interfaces were to function independently, no significant change in overall affinity would be expected. Full-length Rif2, carrying both the RBM and the AAA+ interfaces, showed a Rap1-binding affinity of 30 mM (N = 1.0 ± 0.2) ( Figure 1I ). Given that both Rif2 AAA+ -Rap1 RCT and Rif2 RBM -Rap1 RCT -binding reactions have similar affinities and amplitudes, we interpret the full-length Rif2 titration as a 2(Rap1 RCT ):2(Rif2 full-length) complex (or multiples thereof) with N z 1. This is consistent with the Rif2 RBM and AAA+ interfaces binding Rap1 independently of each other in solution, each contacting a different Rap1 molecule. Thus, a single Rif2 molecule in solution is able to bind one Rap1 molecule through Rif2 AAA+ while holding a second Rap1 in trans through Rif2 RBM . Conversely, it is also true that one Rap1 molecule binds simultaneously to two Rif2 molecules in a nonoverlapping fashion ( Figures 1B, 1F , and S2E).
Rif1 CTD Serves as a Rap1-Binding and Tetramerization Module Next, we turned our attention to Rif1 and examined its mode of Rap1 binding. Using limited proteolysis, we were able to map the Rif1 carboxyl-terminal Rap1-binding domain to residues 1,857-1,916 (data not shown), designated as Rif1 carboxylterminal domain (Rif1 CTD ) (Figure 2A ). Subsequently, we crystallized Rif1 CTD , determined its structure by ab initio methods, and obtained a refined model at a 1.94 Å resolution (Figure 2A ). Rif1 CTD is composed of two antiparallel Rif1 dimers, tetramerizing along a pseudo-2-fold symmetry axis. Structure-based sequence alignment revealed that the Rif1 CTD domain is conserved from yeast to humans ( Figure S3A ). The tetramerization interface of the two dimers utilizes four prominent salt bridges formed by residues R1895 and E1906 from the opposing helix a4 ( Figure 2D ). Using multiangle light scattering (MALS), we confirmed that Rif1 CTD is also tetrameric in solution, the measured molecular weight (MW) being 93 kDa for a Rif1 CTDcontaining fragment (1,709-1,916) and 23.5 kDa for the monomer ( Figure S3B ). Intradimer packing proceeds in canonical knobs-into-holes fashion, largely driven by internal hydrophobic interactions (L1883, I1886, L1894, L1898, and L1905) and surface salt bridges (K1867 to E1897 and R1876 to D1882) (Figures 2B and 2C) . We find that this interface is important for tetramerization, given that an arginine mutation of residue L1905, which is highly conserved across the eukaryotic orthologs ( Figure S3A ), led to a significant reduction in apparent molecular weight in size-exclusion chromatography ( Figure S3B ). The observed molecular weight of Rif1 L1905R (residues 1,709-1,916) by MALS was 35 ± 2 kDa ( Figure S3B ), indicating an equilibrium between a monomer (23.5 kDa) and a dimer (47 kDa) with no apparent sign of tetramerization.
In a previously published Y2H assay, a larger Rif1 construct (1,614-1,916) carrying the Rif1 CTD domain was reported to bind Rap1 RCT (Hardy et al., 1992) . Mutation of E1906K within this construct showed 4-fold reduced binding to Rap1 RCT . However, the diminished interaction due to the E1906K mutation in Rif1 was rescued by a compensatory D727A mutation in Rap1 (identified as the rap1-12 allele) (Hardy et al., 1992) . On the basis of the Rif1 CTD structure from this study, E1906 is located at the Rif1 CTD interdimer interface ( Figure 2D ) where it is only partially solvent accessible. Additionally, we found that mutation of residues L1905R ( Figure 2B ) and R1895E ( Figure 2D ), located at the intradimer and interdimer interfaces, respectively, showed reduced Rap1 binding in a Y2H assay ( Figure 2E ). Although the Rap1-binding defect for L1905R was pronounced, the defect seen with Rif1 R1895E was slightly less severe. The structure demonstrates that L1905 is fully buried in the interface and, thereby, unlikely to bind Rap1 directly ( Figure 2B ), although its mutation to arginine interferes with tetramerization, as judged by size-exclusion chromatography ( Figure S3B ). Therefore, the defect in Rap1 binding seen in the Rif1 CTD mutants is most likely an indirect consequence of tetramerization, possibly because tetramerization is required for assembling the Rap1-binding interface.
A Short Rif1 Peptide Provides a Second Rap1 Binding Site
In our Y2H mutational scanning analysis, we noticed that mutating the Rif1 CTD domain in a construct spanning residues 1,709-1,916 ( Figure 2A ) did not lead to the complete loss of Rap1 binding ( Figure 2E ). Therefore, we examined conserved Rif1 residues outside the Rif1 CTD domain in search of additional, previously uncharacterized Rap1-binding sites. Sequence alignments of Rif1 orthologs from diverse yeast species revealed a conserved 20-amino-acid motif (1,752-1,772) ( Figure 2F ). Mutation of conserved residues within this motif (I1760R, I1762R, or I1764R) abolished Rif1-Rap1 binding in Y2H assays ( Figure 2G ). ITC experiments using a Rif1 construct including both the conserved Rif1 1,752-1,772 peptide and the Rif1 CTD domain showed an interaction with Rap1 at a K d of 20 mM (N = 0.99 ± 0.02) ( Figure 2H ). Mutating the Rif1 CTD still yielded a detectable ITC interaction with an estimated K d of 50 mM (Figures S3C-S3D ). However, a fragment without the conserved peptide motif (1,766-1,916) only carrying the Rif1 CTD domain displayed no detectable binding to Rap1 in ITC ( Figures S3C-S3D ). The conserved Rif1 region comprises residues 1,752-1,772 and, hence, appears to be the major Rap1-binding epitope within Rif1, whereas the Rif1 CTD domain serves as a tetramerization platform and as a secondary, comparably weaker Rap1-binding site in solution.
Next, we set out to study the molecular details of the Rif1 1,752-1,772 peptide interaction with Rap1 RCT . This Rif1 peptide, which, in analogy to Rif2, was named the Rap1-binding module (Rif1 RBM ), cocrystallized with Rap1 RCT and allowed structural analysis of the Rif1 RBM -Rap1 RCT complex at a 1.6 Å resolution ( Figure 2I ). In the crystal, we found three Rap1 RCT molecules in the asymmetric unit complexed by three Rif1 RBM peptides, resulting in an overall 1:1 stoichiometry. The electron density of Rif1 1,760-1,766 was observed for the Rif1 RBM peptide in the structure. Strikingly, the crystal revealed that Rif1 RBM binds Rap1 RCT as a linear peptide at a location identical to that found See also Figure S3 and Table S2. for Rif2 RBM (Figures 2I and 1B) . Like Rif2 RBM , Rif1 RBM binds through extended hydrophobic interactions with Rap1 RCT binding mediated by residues I1760, I1762, I1764, and F1765 (Figure 2I) . Secondary structure prediction and limited proteolysis experiments (data not shown) suggest that Rif1 RBM connects to the tetrameric Rif1 CTD domain through an unstructured linker (residues 1,773-1,856) ( Figure 2A) . Because of the presence of 84 residues between the RBM and CTD domains, this linker is expected to span about 110 Å . Altogether, these data imply that a Rif1 tetramer may bind to more than one (most likely four) Rap1 molecules in solution, in line with the observed stoichiometry in ITC ( Figure 2H ) (each Rif1 CTD tetramer is expected to bind four Rap1 molecules, giving rise to an apparent 1:1 stoichiometry).
Interconnecting Rap1-Rif1 and Rap1-Rif2 Complexes through Overlapping and Nonoverlapping Binding Sites Our structural studies reveal that the RBM domains of Rif1 and Rif2, in complex with Rap1 RCT , fully overlap structurally and, thus, are mutually exclusive. Yet, as judged by the structure, the Rif1 RBM and Rif2 AAA+ interfaces do not overlap ( Figure 3A) , and the Rif2 RBM and AAA+ interfaces most likely engage two different Rap1 molecules. Furthermore, this is supported 3) and Rif1* RBM (I1762R-I1764R) (lanes 4 and 5) or a combination of the two (lanes 6 and 7) were tested against WT Rif1 and Rif2 (lanes 8 and 9). See also Figure S4 and Tables S2 and S3. by published data (Feeser and Wolberger, 2008) , which can now be rationalized by our structures; mutation of a Rap1 surface residue R747, which we found at the Rif2 AAA+ interface ( Figure 1C ), diminished the Rap1-Rif2 interaction by Y2H without affecting the Rap1-Rif1 interaction. The same study demonstrated that mutation of the published Rif1 CTDbinding site on Rap1 (Rap1, D727) reduced Rap1-Rif1-binding in a Y2H assay but retained the Rap1-Rif2 interaction. This indicated that the Rif1 CTD -binding site on Rap1 is also nonoverlapping with both the Rif2 AAA+ and Rif2 RBM or Rif1 RBM interaction sites ( Figure 3A) . Altogether, these data suggest that three of the four Rap1-binding interfaces utilized by Rif1 and Rif2 are nonoverlapping.
Although we did not observe a direct interaction between Rif1 and Rif2 by solution pulldown or Y2H assays (data not shown), the modular nature of these nonoverlapping binding sites nonetheless endows Rif1 and Rif2 with the capacity to simultaneously bind to a common Rap1 molecule, giving rise to a Rif1-Rif2-Rap1 ternary complex bridged by Rap1 ( Figure 3A ).
Rif1 and Rif2
Interconnect Rap1 Units on DNA Arrays Next, we examined if such an interconnection of neighboring complexes may be facilitated on DNA arrays in vitro, where cognate, juxtaposed Rap1-binding sites are expected to generate high local Rap1 concentrations, potentially leading to stable higher-order complexes. Rap1 binds to its cognate recognition site in a noncooperative manner (Gilson et al., 1993; Williams et al., 2010) . Binding occurs independently of the occupancy of adjacent sites, and there was no detectable crosstalk between neighboring Rap1 units on telomeric DNA. We set out to test whether Rif1 and Rif2 serve to interconnect Rap1 units on DNA.
In electromobility shift assays (EMSA) we used a 32 P-labeled 270 bp telomere DNA fragment (Tel270) carrying 14 predicted Rap1-binding sites (Gilson et al., 1994; Williams et al., 2010) . When Tel270 was incubated with increasing amounts of Rap1, we observed characteristic laddering due to stochastic binding of Rap1 to these 14 sites ( Figure S4A ). Then, we loaded Rap1 onto Tel270 and subsequently challenged the Rap1-Tel270 complex with unlabeled specific competitor DNA. Under these conditions, no Rap1 displacement from Tel270 was observed (data not shown). Given the slow dissociation rate of Rap1 from its cognate binding site (k off [1 hr) (Williams et al., 2010) and its reduced stability after 1 hr (see Figure S4B ), we could not pursue equilibrium-based approaches. Therefore, we examined the distribution of Rap1 when incubated simultaneously with labeled Tel270 substrate and unlabeled specific competitors carrying one (Tel19), two (Tel31), or four (Tel80) Rap1-binding sites ( Figure 3B, lanes 3-6) . This experimental setup allows us to measure a kinetic parameter, the association rate (or ''on''-rate), of Rap1 to arrays of different sizes. The amounts of specific competitor DNA were adjusted such that Tel19, Tel31, and Tel80 provided an equivalent concentration of 240 nM Rap1 recognition sites per experiment, whilst having one, two, or four Rap1 sites per competitor duplex, respectively. Rap1 was held at 80 nM with Tel270 present at 1 nM (equivalent of 14 nM Rap1-binding sites). All experiments were carried out in the presence of poly(dIdC), quenching nonspecific DNA interactions. In EMSA, Rap1 now partitioned away from Tel270 towards the excess of unlabeled substrate. The extent of partitioning was independent of the number of binding sites per competitor DNA (Tel19, Tel31, or Tel80) ( Figure 3B , compare fully occupied Rap1-Tel270 in lane 3 with the partially saturated DNA ladders in lanes 4-6), demonstrating that Rap1 exhibits no preference for arrays over single binding sites, as is expected for noncooperative Rap1-DNA binding.
Next, we used this assay to investigate whether the addition of Rif1 and Rif2 may favor Rap1 binding to arrays of binding sites and whether any such preference might be dependent on the multivalent Rap1-binding motifs in Rif1 and Rif2. Full-length Rif2 and Rif1 (1,709-1,916, containing both the Rif1 RBM and the Rif1 CTD domains) were now included in the experiment (Figure 3B , lanes 7-10; note that Rif1 and Rif2 exhibit no Tel270 binding under the conditions used, lane1). Rap1 partitioning was assessed between labeled Tel270 (14 nM Rap1 sites) and unlabeled Tel80 (240 nM Rap1 sites) ( Figure 3B Figure 3B , lane 10) disappeared. Then, we repeated the experiment with Tel19 at different time points (10 min and 1 hr), all of which revealed a qualitative difference for partitioning between Tel270 and Tel19 in the presence, or absence of Rif1 and Rif2 ( Figure S4B ). Rather than competing Rap1 off Tel270, giving rise to free Tel270 DNA and lower Rap1 occupancy, the Rif1-Rif2-Rap1 complexes remained bound to Tel270 under these conditions, revealing a broad distribution of higher molecular weight intermediates (see Figure S4C for detailed explanation). Thus, Tel80 (four sites), Tel31 (two sites), and Tel19 (one site), showing a decreasing number of Rap1-binding sites per molecule but providing the same total number of binding sites per reaction, progressively failed to sequester Rap1 from Tel270 in the presence of Rif1 and Rif2. We conclude that Rif1 and Rif2 enable Rap1, in the biologically relevant time frame of the 90 min generation cycle of dividing yeast cells, to associate with arrays of cognate recognition sites preferentially over individual binding sites, a feature not observed in the absence of Rif1 and Rif2.
The trans-Binding Modules in Rif1 and Rif2 Are Required for Array-Specific Rap1-DNA Interactions Because Rif1 and Rif2 do not bind DNA in the absence of Rap1 in our experimental conditions ( Figure 3B , lane 1), we went on to test whether multivalent long-range Rap1-binding interactions in Rif1 and Rif2 mediate preferential recruitment of Rif1-Rif2-Rap1 to arrays. We used the same experimental setup as in Figure 3B , comparing Rap1 partitioning between Tel270 and Tel19 in the presence of WT Rif1 and Rif2, or various mutants defective in binding neighboring Rap1 units in trans ( Figure 3C ). Our reasoning was that when the Rap1 trans-binding modules of Rif1 and Rif2 are compromised, preferential binding of Rap1 to arrays in the presence of Rif1 and Rif2 would be lost. This would give rise to band-shift patterns similar to those observed for Rap1 alone. We found that mutation in either the Rif1 RBM (I1762R-I1764R) or the Rif2 RBM/AAA+ (E347R-L44R-V45E) motif resulted in a clear loss of preferential binding to Tel270 (Figure 3C , compare lane 8 with lanes 2 and 4), as indicated by the characteristic laddering previously seen for Rap1 in the absence of Rif1 and Rif2 ( Figure 3B, lane 4) . The effect observed when Rif1 RBM and Rif2 RBM/AAA+ motifs were both mutated was only slightly more pronounced than when testing one WT and one mutant version of these proteins in combination ( Figure 3C , compare lane 6 with lanes 2 and 4). Therefore, our data suggest that the preferential binding of Rap1-Rif1-Rif2 assemblies to arrays in vitro requires the long-range Rap1-binding modules (Rif1 RBM and Rif2 RBM/AAA+ ) identified in solution. This provides support for the idea that, in Rif1 and Rif2, both Rap1 trans-binding modules stabilize the protein assembly on arrays of Rap1-binding sites, consistent with the formation of an interlinked scaffold.
The Multivalent Rap1-Binding Sites in Rif1 and Rif2 Function at Telomeres In Vivo Next, we assessed whether the multivalent Rap1-binding motifs in Rif1 and Rif2 are needed for Rif1-and Rif2-mediated telomere homeostasis in yeast. As a first step, we examined Rif1 and Rif2 recruitment to native telomeres. Alleles encoding Rif1 (I1762R-I1764R, conserved among yeast species) ( Figure 2F ), Rif1 (L1905R, highly conserved across all eukaryotes) ( Figure S3A ), Rif2 (E347R), and Rif2 (L44R-V45E) mutant proteins (referred to hereafter as Rif1* RBM , Rif1* CTD , Rif2* AAA+ , and Rif2* RBM [Figure S5A] , respectively) were constructed with a C-terminal Myc tag at their endogenous locus for chromatin immunoprecipitation (ChIP). Western blot analysis indicated that all four mutants are expressed at levels identical to their WT counterparts (Figures S5B-S5C ). ChIP at telomeres on chromosomes VI-R and XV-L showed a 110-and 130-fold enrichment of WT Rif1 protein, respectively ( Figure 4A ). In contrast, both Rif1* RBM and Rif1* CTD proteins showed more than 100-fold reduced telomere localization ( Figure 4A ). We note that a Rif1* RBM/CTD double mutant has telomere occupancy similar to the single mutants ( Figure 4A ), indicative of a possible background level of Rif1 binding.
ChIP analysis of WT Rif2 at telomeres revealed a 7-and 10-fold enrichment on chromosomes VI-R and XV-L, respectively ( Figure 4B ). We observed that Rif2* RBM and Rif2* AAA+ mutants reproducibly showed reduced binding to about 50% and 30% of that seen in the RIF2 WT strain, and a slight additional decrease was observed in a strain expressing the Rif2* RBM/AAA+ double mutant protein, perhaps to background levels ( Figure 4B ). These in vivo results are particularly remarkable for Rif1* CTD , which showed a clear defect in tetramerization, and Rif1 CTD exhibited weaker Rap1 binding than Rif1 RBM in vitro. Given that Rif1* CTD does not aggregate in vitro ( Figure S3B ) and is expressed at WT levels in cells (Figure S5B ), the Rif1* CTD phenotype is a consequence of impaired Rap1 binding due to defects in tetramerization. In conclusion, all Rap1-binding interfaces in Rif1 (RBM and CTD) and Rif2 (RBM and AAA+) are functional in vivo, where they are required for efficient recruitment of Rif1 and Rif2 to telomeres.
Rap1-Binding Modules in Rif1-Rif2 Are Required for Wild-Type Telomere Length Regulation Next, we tested whether decreased Rif1 or Rif2 telomere occupancy, due to mutation of the multivalent long-range Rap1-binding modules, was sufficient to elicit a biological response strong enough to interfere with telomere homeostasis. Rif1 and Rif2 negatively regulate telomere length in a telomerasedependent manner (Hardy et al., 1992; Levy and Blackburn, 2004; Wotton and Shore, 1997) . Deletion of RIF1 gives rise to an approximate 300 bp increase in average telomere TG tract length ( Figure 4C ) (Hardy et al., 1992) . Whereas telomere elongation for rif1* RBM and rif1* CTD was pronounced (150 bp), the phenotypes did not correspond to that of a full RIF1 deletion ( Figure 4C) . A Rif1 mutant strain lacking its entire Rap1 binding C terminus (rif1_DC) also gave rise to an intermediate telomere length phenotype, very similar to that seen for the rif1* RBM single mutant ( Figure S5D) .
Loss of RIF2 also results in a telomere elongation phenotype, though one that is less pronounced than that seen for the loss of RIF1 (Wotton and Shore, 1997) . We found that rif2* RBM and rif2* AAA+ strains had non-WT telomeres with TG tract length increases of 50 bp in comparison to the WT strain ( Figure 4D ).
In conclusion, rif1* RBM , rif1* CTD , rif2* RBM , and rif2* AAA+ , defective in Rap1 binding and telomere localization, also show defects in telomere length regulation.
Rap1-Binding Modules in Rif1-Rif2 Are Required for Antagonizing SIR-Mediated Silencing The Rif1 and Rif2 capping complex antagonizes transcriptional silencing of genes placed in the vicinity of telomeres, also known as telomere position effect (TPE) (Wotton and Shore, 1997; Gottschling et al., 1990; Kyrion et al., 1993) . Telomeric silencing utilizes most of the genes (SIR2, SIR3, and SIR4) required for silencing of the HM loci (Aparicio et al., 1991) . Deletion of RIF1, and to a lesser extent RIF2, triggers increased telomeric silencing (Wotton and Shore, 1997) , presumably because Sir and Rif proteins compete for binding to the Rap1 RCT domain at telomeres. This notion of competitive interplay between Sir and Rif proteins at telomeres is strongly supported by earlier Y2H analysis (Wotton and Shore, 1997) , although the detailed molecular basis of this effect is currently unknown.
Using X-ray crystallography, Chen et al., 2011 previously observed that a Sir3 peptide (Sir3 RBM ) binds the Rap1 RCT domain. Now, our results show that the Rap1-binding motifs in Sir3, Rif1, and Rif2 occupy the same binding groove on Rap1 ( Figure 4E ). On the basis of structural superposition, Sir3 RBM , Rif1 RBM , and Rif2 RBM within this Rap1 RBM-binding groove are fully overlapping and, hence, mutually exclusive ( Figures  4F-4G) . Surprisingly, the secondary structure motifs of the RBM domains used for Rap1 binding differ, as does the directionality of the protein chains, revealing an unexpected structural plasticity. This was not anticipated on the basis of sequence analysis and precluded prior recognition of Rif1 and Rif2 RBM motifs (see Figure S5H -S5I).
To ask whether the Rif1 and Rif2 scaffold competes through its RBM domains with Sir3 for binding Rap1 in vivo, we used standard reporter genes placed at a truncated telomere (telVII-L::URA3) ( Figure 4H , see Extended Experimental Procedures for a detailed description). The rif1* RBM mutant strain was found to exhibit a 100-fold increase in URA3 repression (as measured by the fluoroorotic acid [FOA] growth assay), an effect similar to that seen in a rif1D strain, and indicative of increased Sir3 activity at the locus. Similarly, mutations in the RBM motif of Rif2 (rif2* RBM ) gave rise to a TPE phenotype comparable to that of rif2D cells. The rif1* RBM /rif2* RBM double mutant showed a greater than additive increase in URA3 repression (10 3 -fold), indicating that the RBM domains of Rif1 and Rif2 synergistically antagonize telomeric silencing. We note that the TPE effects of rif1* RBM and rif2* RBM cannot be explained by an indirect effect acting through telomere length, given that, in otherwise WT cells, an increase of >600 bp is required to affect TPE (Kyrion et al., 1993) Figure S5F , and data are represented as mean ± SD. (C and D) Rif1 and Rif2 mutations that compromise Rap1 binding cause elongated telomeres. Genomic DNA was isolated from rif1 (C) and rif2 (D) mutant strains, digested with XhoI, and subjected to southern blotting with a telomeric TG 1-3 repeat probe.
(E) Superposition of the Rif1 RBM (cyan)-Rap1 RCT (yellow), Rif2 RBM (red)-Rap1 RCT , and Sir3 RBM (gray)-Rap1 RCT structures illustrating that the binding of the three peptides to the Rap1 RBM groove is expected to be mutually exclusive because of steric clashes. Sir3 RBM binds in reverse orientation with respect to Rif1 RBM and Rif2 RBM .
(legend continued on next page) Rif1, which had the most pronounced effects on silencing ( Figure 4H ) (Wotton and Shore, 1997; Feeser and Wolberger, 2008) . Silencing assays at telomeres revealed a comparable magnitude of silencing effects for rif1* CTD and rif1* RBM mutant strains ( Figure 4I ). This observation correlates with the similar decrease of Rif1* CTD and Rif1* RBM mutant proteins in their telomere occupancies, as measured by ChIP ( Figure 4A ). Thus, silencing changes in rif1 mutants are primarily caused by reduced Rif1 telomere occupancy because of an impaired Rap1 interaction. Furthermore, we conclude that all Rap1-binding domains tested in Rif1 (Rif1 RBM and Rif1 CTD ) and Rif2 (Rif2 RBM ) are simultaneously needed for modulating telomeric silencing in vivo.
Mutations of Rap1-Binding Interfaces in Rif2, but Not in Rif1, Trigger the G2/M Checkpoint at Telomeric DSBs Defects in replication, repair, or telomere capping trigger a G2/ M checkpoint arrest (reviewed in Lisby and Rothstein, 2004) . We used a single-cell assay to assess the role of the Rif1 and Rif2 scaffold in inhibiting the G2/M checkpoint activation triggered by an HO-endonuclease-induced DSB flanked by 80 bp telomere tracts (TG80) (Michelson et al., 2005) . WT Rif1 and Rif2 are required for the prevention of short TG80 telomeric tracts from initiating a DNA-damage response that arrests the cell cycle, each deletion mutant giving rise to a transient G2/M delay of about 1 hr after HO-induced cleavage (Ribeyre and Shore, 2012) . Using our Rif1 and Rif2 mutants, we found that rif2* AAA+ caused a G2/M arrest (1 hr) comparable to that seen in the rif2D strain ( Figure 5A ), whereas mutations in the Rif2 RBM domain (rif2* RBM ) led to a slightly shorter arrest of 30-45 min ( Figure 5A ). Thus, both long-range Rif2 RBM and Rif2 AAA+ interfaces, used for Rap1 binding and telomere recruitment, are needed for the prevention of inappropriate G2/M checkpoint activation at short telomeres in vivo. When testing the Rif1 mutants in the G2/M assay, we found that the single rif1* RBM or rif1* CTD mutant strains did not significantly delay cell-cycle progression ( Figure 5B ), although rif1D did. This was observed despite the fact that the Rif1* CTD and Rif1* RBM mutant proteins appear to be practically absent at normal, undamaged telomeres and display clear phenotypes in telomere length regulation and transcriptional silencing. Thus, we examined in detail whether Rif1* RBM or Rif1* CTD mutant proteins are recruited to telomeric DSBs despite their compromised Rap1 binding. Before HO-mediated DSB formation at the duplicated TG80 arrays, WT Rif1 is clearly detectable, whereas Rif1* RBM or Rif1* CTD binding appears considerably lower ( Figure 5C ). The reduced presence of Rif1* RBM and Rif1* CTD is in line with our observation of decreased recruitment of these mutants to native telomeres ( Figure 4A ). Following HO cutting, additional WT Rif1 is recruited to both TG80 ends, perhaps partly because they are actively elongated. Surprisingly, Rif1* RBM and Rif1* CTD were also readily detectable at the HO-cut TG80 ends ( Figure 5C ), albeit at lower levels in comparison to the Rif1 WT protein. The fold increase of WT Rif1 and Rif1* RBM (or Rif1* CTD ) at the TG80 tracts before and after HO induction was comparable (5-fold). A Rif1* RBM/CTD double mutant, expected to be further compromised in Rap1 binding, was, nonetheless, recruited to the TG80 ends and showed a WT G2/M checkpoint response, (Figures 5B and  5C ). Although they are defective in telomere binding, length regulation, and silencing, the rif1* RBM and rif1* CTD mutant strains exhibit a separation-of-function phenotype with respect to their G2/M checkpoint role allowing for Rap1-independent recruitment to telomeric DSBs (see Figures S6A-S6B for further characterization and discussion of Rif1 G2/M separation of function).
In summary, we have observed that Rif1 and Rif2 bestow specific binding of Rap1 to arrays of Rap1 binding sites in vitro in a manner dependent on the Rif1 and Rif2 multivalent longrange Rap1-binding interactions identified by structural means. We found that these multivalent interactions are all required for Rif1 and Rif2 telomere binding and modulating telomeric silencing in vivo. In the case of Rif1, defects in the long-range Rap1-binding modules had no discernable effect on Rif1-mediated G2/M checkpoint inhibition, although other phenotypes related to telomere length regulation and silencing were detected.
DISCUSSION
Model for Rap1-Rif1-Rif2 Assembly at Telomeric Arrays The structural and biochemical findings reported here allow us to define the principal structural building blocks of the higher-order telosome assembly at double-stranded Rap1-binding site repeats. Rap1-Rif2: Interconnecting Neighboring Rap1 Units Rif2 can bind individual Rap1 molecules either through its AAA+ or RBM interfaces, both of which have comparable affinity. When neighboring Rap1 molecules are spaced in close proximity, Rif2 is expected to be able to interconnect two Rap1 molecules in trans using both interfaces connected through a flexible linker. A hypothetical model of such an assembly, assuming Rap1-binding sites are set apart by 19 bp, is shown (F) Structure-based sequence alignment of the RBM motifs in Rif1, Rif2, and Sir3. Helices are denoted as cylinders. Equivalent hydrophobic residues in Rif1 RBM , Rif2 RBM , and Sir3 RBM involved in Rap1 binding are highlighted in red. (G) Stick representations of residues from Rif1 RBM , Rif2 RBM , and Sir3 RBM that interact with Rap1 RCT (shown in cartoon representation). RBM peptide polarity is indicated in rainbow coloring from red for N termini to green for C termini. (H) Rif1 and Rif2 compete with Sir3 for the Rap1 RBM-binding groove in vivo. Telomeric silencing was assayed with a telVII::URA3 reporter (relevant genotypes and yeast strains are listed in Table S2 ). Growth on medium containing 5-FOA indicates increased telomeric silencing. rif1* RBM , rif2* RBM or rif1* RBM , and rif2* RBM mutants give rise to silencing phenotypes similar to those seen after the deletion of RIF1, RIF2 or RIF1, and RIF2, respectively. (I) Mutation of any of Rap1-binding interfaces (Rif1 RBM or Rif1 CTD ) in Rif1 similarly affect telomeric silencing. Silencing assays were performed as in (H) with rif1* RBM , rif1* CTD or rif1 deletion strains. See also Figure S5 and Table S2 .
in Figure 6A . Because of the length restriction of the Rif2 flexible linker connecting the RBM and AAA+ domains (spanning a maximal length of 42 Å ), Rif2-Rap1 trans binding is expected to be dependent on the DNA spacing and the radial orientation between Rap1-binding sites. The system is most likely expected to be plastic, given that Rap1 RCT is connected to the remainder of Rap1 through a flexible linker (70 Å to maximally 90 Å in length) and Rap1 binding may induce distortion of the DNA (Gilson et al., 1993) . Rap1-Rif1: Interconnecting Distal Rap1 Units The Rif1 RBM epitope is attached to its Rif1 CTD domain via a 110 Å linker. Although Rif1 RBM appears to be the major Rap1-binding site in our in vitro assay, Rif1 CTD plays only an accessory role. However, we observed in vivo that both the RBM and CTD domains are of equal importance in telomere homeostasis. On the basis of molecular modeling, we estimate that Rif1, with its four RBM domains coupled to its tetramerization CTD domain, can interlink up to four neighboring Rap1 units over 30 bp of spacing between Rap1-binding sites ( Figure 6B ). Thus, the Rif1 RBM tetramer with its predicted end-to-end distance of 2 3 110 Å is expected to bridge Rap1 molecules over longer distances in comparison to Rif2. Mixed Rap1-Rif1 and Rap1-Rif2 Interconnections Although the Rif1 RBM and Rif2 RBM interfaces on Rap1 are directly overlapping, the Rif1 RBM or Rif2 RBM interfaces are not mutually exclusive with those of Rif2 AAA+ and Rif1 CTD (structural studies Figures 1, 2 , and 3A and mutagenesis by Feeser and Wolberger, 2008) . This allows Rap1, once its RBM-binding groove is occupied by either Rif1 or Rif2, to bind neighboring Rif2 or Rif1 molecules through the AAA+ or CTD interfaces, respectively ( Figure 6C ). The Velcro Model for Telomere Organization Now, we provide the biochemical, biophysical, and structural characterization of Rap1, Rif1, and Rif2 binding to telomeric arrays. In vitro, a higher-order interlinked scaffold exists when reconstituting Rap1, Rif1, and Rif2 on a native telomeric DNA substrate ( Figures 3B and 3C ). Such interlinking also appears to operate in vivo. The Rif1 RBM domain is the main Rap1-binding site, although the CTD domain has a lower Rap1 affinity, providing trans binding through tetramerization. However, in vivo, neither one alone suffices as a Rap1-binding Figure S5A ) is plotted against time, indicating cell-cycle progression. The average restart time for each strain (indicated in parentheses along with the number of measured cells) was estimated with a Kaplan-Meier survival analysis (see also Table 1 ). (B) Mutations of Rap1-binding interfaces in Rif1 do not activate an inadvertent checkpoint response. G2/M arrest assays were performed as in (A) with the indicated strains (Rif1 mutations are shown in Figure S5A ) or a rif1 deletion strain (listed in Table S2 ). (C) Rif1 mutant proteins are recruited to telomeric DSBs. Cells expressing Myc-tagged WT Rif1 or Rif1 mutant proteins were analyzed by ChIP before and after HO cleavage at TG80 telomeric tracts. Calculations were performed as in Figure 4A , and values are listed in Figure S5G . Data are represented as mean ± SD. See also Figure S6 and Table S2. module for telomere recruitment of Rif1. Similarly for Rif2, mutation of either Rap1-binding site (Rif2 RBM or Rif2 AAA+ ) was equivalent to the disruption of both sites simultaneously. Altogether, this suggests that multivalent weak Rap1-binding modules provided by Rif1 and Rif2 serve in stabilizing telosome formation in vivo. Furthermore, the observed Rap1 pref- Figure S7 .
erence for arrays in the presence of Rif1 and Rif2 in vitro provides a biochemical rationale for the preferential binding of Rap1-Rif1-Rif2 to telomeres in vivo. The exact spatial organization and local concentrations of Rap1, Rif1, and Rif2 on telomeres is unknown. On the basis of our data, we propose a model where interactions (Figures 6A-6C ) identified by structural means, characterized in solution, and found to bestow arrayspecific Rap1 binding to telomeric DNA would predict a high propensity for Rap1-Rif1-Rif2 to form a molecular Velcro, in which Rap1 units become interlinked in a Rif1-and Rif2-dependent manner in vivo. Rap1 affinities provided by Rif1 RBM , Rif2 RBM , and Rif2 AAA+ appear balanced (20-50 mM), in principle allowing a stochastic combination of the different possible binding modes. We favor a model where Rap1, Rif1, and Rif2 form a heterogeneous assembly rather than a defined stoichiometric complex ( Figure 6D ), given that this may be better adapted to accommodate the irregular DNA spacing found at telomeric Rap1 site arrays in budding yeast (see also Figure S7 ).
The Velcro-like binding mode utilizing arrays of weak binding sites confers plasticity to structures such as the telosome, allowing them to undergo disassembly and reformation in every S phase while providing stability in the other phases of the cell cycle.
Higher-Order Architectures Serving a Biological Function
The structural and functional characterization of Rif1 and Rif2 enabled us to dissect the molecular contribution of this scaffold to telomere homeostasis. Mutations in any of the Rap1-binding modules in Rif1 and Rif2 resulted in defects in Rif1 and Rif2 telomere recruitment ( Figures 4A and 4B ) and, as a consequence, defective telomere length regulation ( Figures 4C and 4D) . Similarly, mutations in the Rif1 RBM , Rif1 CTD , and Rif2 RBM motifs gave rise to transcriptional silencing effects. In silencing, we find, surprisingly, that the structural RBM motifs constituting an important part of the Velcro architecture directly and functionally compete with Sir3 for binding to Rap1. Thus, the Velcro is not only an array-specific recruitment mechanism but also a functional architecture. Although it is speculative at this point, a more direct role of the Velcro in sterically protecting telomeres from nucleases or regulating telomere length through limiting telomerase access (Gallardo et al., 2011) deserves further attention in the future.
Organizing DNA Arrays
This work provides insights into how genomic arrays (telomeric Rap1-binding sites) are packaged through array-specific complexes, such as Rif1 and Rif2, into higher-order structures, which are, in turn, required for telomere function. Genome sequences in many organisms often contain a large number of repeated units that bind pleiotropic transcription factors. The multivalent long-range interaction network observed herein, and the resulting Velcro architecture, would allow dedicated protein complexes to bring novel biological functions specifically to these repeated DNA domains.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification S. cerevisiae Rap1 and Rif1 constructs were expressed in Escherichia coli, and full-length Rif2 was produced in insect cells. Expression and purification procedures are outlined in the Extended Experimental Procedures.
Crystallization and Structure Determination
Rif2 was solved by single-wavelength anomalous dispersion. The Rif2-Rap1 complex structure was solved by molecular replacement with the Rif2 structure and that of the Rap1 C-terminal domain. The Rif1 CTD was solved by ab initio methods. Details for crystallization, data collection, structure determination, and refinement statistics are given in Table S1 and the Extended Experimental Procedures.
Biochemical Assays
Isothermal calorimetry, DNA substrate preparation, and analysis by EMSA are outlined in the Extended Experimental Procedures.
Cellular Assays
Y2H experiments were performed as outlined in Hardy et al., 1992 , and the telomere blots and G2/M assay performed are described in Ribeyre and Shore, 2012 . For experimental details and the design of silencing assays, please refer to the Extended Experimental Procedures.
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The models and structure factors have been deposited in the Protein Data Bank with the PDB under accession numbers 4BJ1 (Rif2 66-380 ), 4BJ5 (Rif2 1-395 -Rap1 RCT ), 4BJ6 (Rif2 35-395 ), 4BJT (Rif1 RBM -Rap1 RCT ), and 4BJS (Rif1 CTD ).
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